Article Versions Notes

Manai M, ELBini-Dhouib I, Finetti P, Bichiou H, Reduzzi C, Aissaoui D, Ben-Hamida N, Agavnian E, Srairi-Abid N, Lopez M, et al. MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer. Cells. 2022; 11(18):2926. https://doi.org/10.3390/cells11182926

Manai, Maroua, Ines ELBini-Dhouib, Pascal Finetti, Haifa Bichiou, Carolina Reduzzi, Dorra Aissaoui, Naziha Ben-Hamida, Emilie Agavnian, Najet Srairi-Abid, Marc Lopez, and et al. 2022. "MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer" Cells 11, no. 18: 2926. https://doi.org/10.3390/cells11182926

Manai, M., ELBini-Dhouib, I., Finetti, P., Bichiou, H., Reduzzi, C., Aissaoui, D., Ben-Hamida, N., Agavnian, E., Srairi-Abid, N., Lopez, M., Amri, F., Guizani-Tabbane, L., Rahal, K., Mrad, K., Manai, M., Birnbaum, D., Mamessier, E., Cristofanilli, M., Boussen, H., ... Bertucci, F. (2022). MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer. Cells, 11(18), 2926. https://doi.org/10.3390/cells11182926